May 25, 2020

Legend Biotech – $150.5 Mllion

Date posted: 04/12/2020

Business location: Somerset, NJ

Amount Funded: $150.5  Million

Type: Series A

Participating Investor(s):  Hudson Bay Captital Management LP, Johnson & Johnson Innovation, Lilly Asia Ventures, Vivo Captial, RA Capital Managment, Other investors

Note:  Investors in red are new investors to this company.

Total Funding to Date: not listed

Company Description: Legend Biotech is a global, clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. Legend Biotech has functional sites in the United States, Europe, and mainland China.

What funding will be used for:  Advance research and development, commercialization of its pipeline programs, expansion or manufacturing facilities, enhancement of research and development platform, general corporate expenses. 

For more information:  media@legendbiotech.com

Data provided by respective company (unless otherwise noted) and researched by StartupsOne for accuracy. 

 

StartupsOne

StartupsOne features relevant, focused news on venture capital funding of technology oriented startup businesses based in North America.

View all posts by StartupsOne →